Market Currents
AstraZeneca (AZN) says it received a favorable ruling from the U.S. District Court in New Jersey...
-
Friday, March 30, 2012, 2:54 AM ETAstraZeneca (AZN) says it received a favorable ruling from the U.S. District Court in New Jersey that the formulation patent for its anti-psychotic drug Seroquel XR was valid. Torrent Pharmaceuticals and Mylan (MYL) were among those named that the court said had infringed the patent.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
